Stüve, Olaf <br/><br/>
Iatrogenic immunosuppression with biologics in MS: expecting the unexpected?  [electronic resource] 

 -  Neurology  Oct 2009 
 - 1346-7 p.  digital 
<br/><br/> Publication Type: Comment; Editorial 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/WNL.0b013e3181beed38  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Clinical Trials as Topic<br/>Humans<br/>Iatrogenic Disease<br/>Immune Tolerance<br/>Integrin alpha4--metabolism<br/>Leukoencephalopathy, Progressive Multifocal--chemically induced<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Natalizumab<br/>Risk<br/>Toxoplasma<br/>Toxoplasmosis, Ocular--etiology